Literature DB >> 11978619

Lack of association of the -1171 (5A) allele of the MMP3 promoter with breast cancer.

Haixin Lei, Jan Zaloudik, Igor Vorechovsky.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11978619

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  6 in total

1.  Analysis of common germline polymorphisms as prognostic factors in patients with lymph node-positive breast cancer.

Authors:  Gudrun Knechtel; Günter Hofmann; Armin Gerger; Wilfried Renner; Tanja Langsenlehner; Joanna Szkandera; Gerald Wolf; Hellmut Samonigg; Peter Krippl; Uwe Langsenlehner
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-05       Impact factor: 4.553

2.  Functional Significance of MMP3 and TIMP2 Polymorphisms in Cleft Lip/Palate.

Authors:  A Letra; M Zhao; R M Silva; A R Vieira; J T Hecht
Journal:  J Dent Res       Date:  2014-05-05       Impact factor: 6.116

3.  The collagenase-1 (MMP-1) gene promoter polymorphism - 1607/2G is associated with favourable prognosis in patients with colorectal cancer.

Authors:  A Hettiaratchi; N J Hawkins; G McKenzie; R L Ward; J E Hunt; D Wakefield; N Di Girolamo
Journal:  Br J Cancer       Date:  2007-02-20       Impact factor: 7.640

4.  Association of matrix metalloproteinase-3 -1171(5A>6A) polymorphism with cancer risk: a meta-analysis of 41 studies.

Authors:  Xin Yang; Jing-Wen Hu; Man-Tang Qiu; Ming Li; Rong Yin; Jie Wang; Lin Xu; Qin Zhang
Journal:  PLoS One       Date:  2014-01-29       Impact factor: 3.240

5.  Matrix metalloproteinase 1, 3, and 9 polymorphisms and esophageal squamous cell carcinoma risk.

Authors:  Xuan Guan; Xiang Wang; Hao Luo; Jing Wu; Xiao Zhang; Jin Wu
Journal:  Med Sci Monit       Date:  2014-11-13

Review 6.  Matrix Metallopeptidase 3 Polymorphisms: Emerging genetic Markers in Human Breast Cancer Metastasis.

Authors:  Shafinah Ahmad Suhaimi; Soon Choy Chan; Rozita Rosli
Journal:  J Breast Cancer       Date:  2020-02-18       Impact factor: 3.588

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.